Phase III Testing is defined as what?

• A. Investigational New Drug (IND)
• B. Placebo
• C. Double-Blind Study
• D. Phase III Testing

Answer: (D)

Phase III testing is the stage where the drug is evaluated in a large and diverse group of patients to confirm that it works and to closely monitor safety. These studies are usually randomized and controlled, often conducted at multiple centers, and compare the new treatment to a placebo or to the current standard therapy. The goal is to gather robust data on efficacy and adverse effects to support regulatory approval and labeling. That precise description matches the idea of Phase III Testing. The other options refer to unrelated concepts: an IND is the filing to begin human trials, a placebo is a control substance, and a double-blind study is a design feature that can appear in various phases but isn’t the phase itself.